HERA HEALTH SOLUTIONS LIMITED

Hera Health Solutions Limited is a cutting‑edge biotechnology company dedicated to reshaping the landscape of drug delivery. Leveraging a proprietary nanotechnology‑enabled platform, the firm reformulates existing active pharmaceutical ingredients (APIs) into more effective, long‑acting therapies, accelerating the path from research to commercialisation.

Their core services span product and API optimisation, the creation of upgraded and customisable release profiles, and the resolution of toxicity challenges through biodegradable, patient‑optimised solutions. All manufacturing processes employ FDA‑ and GMP‑approved facilities and materials, ensuring cost‑efficient, scalable production that meets the stringent standards of the pharmaceutical industry.

By partnering with global pharmaceutical players, Hera Health Solutions delivers rapid reformulation capabilities that enhance therapeutic performance while reducing development timelines, positioning itself as a pivotal ally for companies seeking innovative, reliable drug‑delivery technologies.